Atwood & Palmer’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.8K Sell
56
-2
-3% -$846 ﹤0.01% 319
2026
Q1
$27.4K Buy
58
+2
+4% +$1.01K ﹤0.01% 299
2025
Q4
$26.1K Sell
56
-26
-32% -$12.1K ﹤0.01% 299
2025
Q3
$34.9K Hold
82
﹤0.01% 277
2025
Q2
$31.4K Hold
82
﹤0.01% 273
2025
Q1
$28.3K Buy
+82
New +$26.4K ﹤0.01% 265

Other funds holding HCA

Atwood & Palmer's HCA Position: Q2 2026 in Review

Atwood & Palmer reduced its HCA Healthcare (HCA) stake by 3.4% in Q2 2026, selling an estimated $846 and leaving 56 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Atwood & Palmer first reported a position in HCA in Q1 2025 and has held it in 6 quarters since. The position peaked at $34.9K in Q3 2025. 386 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Atwood & Palmer held 56 shares of HCA Healthcare worth $21.8K as of Q2 2026.
  • Atwood & Palmer sold 2 HCA Healthcare shares in Q2 2026, an estimated $846.
  • HCA Healthcare made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #319 holding.
  • Atwood & Palmer first reported a position in HCA Healthcare in Q1 2025 and has held it in 6 quarters since.
  • Atwood & Palmer's HCA Healthcare position peaked at $34.9K in Q3 2025.
  • 386 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.